Q: Your thoughts, any reason for pop thanks
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Please analyze this company from investment perspective. Thanks
Q: Could you comment on ECO's earnings? Thanks.
Q: I have heard positive things about the management of EWS. They are certainly in the right space. Can you comment on their prospects from a financial & competitive standpoint?
-
Sangoma Technologies Corporation (STC $6.81)
-
Photon Control Inc. (PHO $3.60)
-
Xebec Adsorption Inc. (XBC $0.51)
Q: Hello, Which small cap stock looks more attractive after the recent correction? Thank you.
Regards,
Shyam
Regards,
Shyam
Q: Hi 5i Team,
Converge Technology and Sangoma Technology, which one you think would have better upside potential?
Thank you for your professional advice as always.
Converge Technology and Sangoma Technology, which one you think would have better upside potential?
Thank you for your professional advice as always.
Q: Your thoughts on this company for a coal play, and rising economy. I also like the dividend. What other companies would you prefer?
Q: Do either of these two look compelling to you at this point ? If so - do you have a preference ?
Thank you .
Thank you .
Q: following the current results ... would you not expect a positive response from the market? ... why the negative response ..thx
Q: AT taking a hit again in early trading. Is it time to move on. Thanks
Q: Please your thoughts on Herc Holdings
Q: Hi there. What is your opinion on bombardier and what is their go forward outlook?
Q: RE my question about criteria for buyable microcaps. I cannot remember anything specific to help locate this item in the feed. As an alternative, could you suggest several criteria to help deciding if a microcap is worth considering for purchase: e.g., certain level of booked revenues etc.
Thanks, David
Thanks, David
Q: could i have your opinion on this company please.Is there a reason for weakness in the share price recently?
Q: Could you please compare these two companies post split. What is the business area differences they seem to very similar.
Could you also comment on their recent earning and potential trajectory.
Vmd raised a lot of money and I don’t see any action
Ptq seems to be more aggressively growing their business and very positive. Vmd is very quiet and not promotional. The both seem to be in an excellent space long and short term.
Could you also comment on their recent earning and potential trajectory.
Vmd raised a lot of money and I don’t see any action
Ptq seems to be more aggressively growing their business and very positive. Vmd is very quiet and not promotional. The both seem to be in an excellent space long and short term.
Q: Please provide you opinion on SHG. It appears that they are competing in the same space as WELL. Understanding that SHG carries more risk, which company has the strongest growth profile for the next several years?
Q: Any thoughts lately on this co. as their outlook seems impressive but not the stock. thanks
Q: Could you please comment on VHI's latest licensing deal.
Thanks as always.
VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a multi-year large-scale licensing transaction of recently acquired subsidiary Intouch with Health’s (“Intouch”) Synopsis product with South Tees Hospitals NHS Foundation Trust (the “Trust” or “South Tees”).
This transaction is among VitalHub’s largest to-date, comprising a 5-year licensing contract for the Company’s proprietary, award-winning Synopsis platform. From initial questionnaire through to post-operative outcomes, Synopsis provides the necessary tools to enable hospitals to manage the entire pre-operative assessment process digitally – removing paper trails, increasing data security, and delivering significant organizational and economic benefits.
Thanks as always.
VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a multi-year large-scale licensing transaction of recently acquired subsidiary Intouch with Health’s (“Intouch”) Synopsis product with South Tees Hospitals NHS Foundation Trust (the “Trust” or “South Tees”).
This transaction is among VitalHub’s largest to-date, comprising a 5-year licensing contract for the Company’s proprietary, award-winning Synopsis platform. From initial questionnaire through to post-operative outcomes, Synopsis provides the necessary tools to enable hospitals to manage the entire pre-operative assessment process digitally – removing paper trails, increasing data security, and delivering significant organizational and economic benefits.
Q: What is your opinion on NEO? Thank you
Q: Hi 5i Team!
I would be interrested in your view on Vitreous Glass Inc. The Ticker is VCI.
It came across my radar this afternoon, looks to me to be very underestimated.
Trading at $4.29. Average Price Target on Yahoo is $30.50. with a 12% dividend.
I'd love to get your thoughts. Looks to be very undervalued.
Thanks!
I would be interrested in your view on Vitreous Glass Inc. The Ticker is VCI.
It came across my radar this afternoon, looks to me to be very underestimated.
Trading at $4.29. Average Price Target on Yahoo is $30.50. with a 12% dividend.
I'd love to get your thoughts. Looks to be very undervalued.
Thanks!